News
Media And Political Bulletin – 02 March 2020
Media and Political Bulletin 02 March 2020
|
Media Summary |
FDA reports first coronavirus-related drug shortage
CNBC, Berkeley Lovelace Jr., 28 February 2020 CNBC reports that the FDA has said the pharmaceutical industry has reported the first shortage of a drug due to the COVID-19 outbreak. The FDA, which declined to identify the drug, said the shortage is related to a manufacturing site impacted by the outbreak in China. “It is important to note that there are other alternatives that can be used by patients. We are working with the manufacturer as well as other manufacturers to mitigate the shortage,” the agency said in its notice. The FDA also said it has been in touch with more than 180 manufacturers of human drugs since 24 January, asking them to evaluate their entire supply chain and other components manufactured in China. 10 things you should know about the English pharmacy contract update C+D, Valeria Fiore, 28 February 2020 While the overall funding for community pharmacy is fixed at £2.592bn per year until 2024, the number of services offered by the sector will grow in 2020-21. An update on the English community pharmacy contractual framework (CPCF) for 2019-20 to 2023-24, shared with contractors last week (February 23), offers more detail about some of the services first announced in the contract last year. C+D gives their pick of the 10 key updates contractors need to get ready for.
|
Parliamentary Coverage |
Medicines and Medical Devices Bill: overarching documents
Department of Health and Social Care, 28 February 2020 Further documents relating to the Medicines and Medical Devices Bill 2020 have been published:
|
Full Coverage |
FDA reports first coronavirus-related drug shortage
CNBC, Berkeley Lovelace Jr., 28 February 2020 The Food and Drug Administration said the pharmaceutical industry reported the first shortage of a drug due to the COVID-19 outbreak that has spread to 44 countries in a matter of weeks. The FDA, which declined to identify the drug, said the shortage is related to a manufacturing site impacted by the outbreak in China. “The shortage is due to an issue with manufacturing of an active pharmaceutical ingredient used in the drug,” the agency said in its notice dated Thursday. “It is important to note that there are other alternatives that can be used by patients. We are working with the manufacturer as well as other manufacturers to mitigate the shortage.” The agency has been warning consumers that the impact to the medical supply chain would likely impact their own lives, including potential disruptions to prescription drugs or shortages of critical medical products in the United States. China, where the outbreak began in late December, is a large supplier of active pharmaceutical ingredients used to make several medicines. China this week began reopening operations for a number of businesses, but travel restrictions that are still in place are likely to slow down production. The FDA also said it has been in touch with more than 180 manufacturers of human drugs since Jan. 24. The agency is asking them to evaluate their entire supply chain and other components manufactured in China. “Also, as part of our efforts, the FDA has identified about 20 other drugs, which solely source their active pharmaceutical ingredients or finished drug products from China,” the agency said. 10 things you should know about the English pharmacy contract update C+D, Valeria Fiore, 28 February 2020 While the overall funding for community pharmacy is fixed at £2.592bn per year until 2024, the number of services offered by the sector will grow in 2020-21. An update on the English community pharmacy contractual framework (CPCF) for 2019-20 to 2023-24, shared with contractors last week (February 23), offers more detail about some of the services first announced in the contract last year. Changes include the introduction of the NHS Discharge Medicines Service, which community pharmacies will be expected to provide a new essential service from July. As part of this, hospitals will be able to digitally refer patients to their pharmacy for guidance on newly prescribed medicines or updated prescriptions. Pharmacies will continue to deliver the Community Pharmacist Consultation Service (CPCS), which will be expanded to include referrals from NHS 111 online in June, and from GP practices later this year. The Pharmaceutical Services Negotiating Committee (PSNC) is still finalising the details of each service, in collaboration with NHS England and the Department of Health and Social Care (DH) and working towards an agreement on the payment contractors will receive in 2020-21. Here is our pick of the 10 key updates contractors need to get ready for:
|
